125 related articles for article (PubMed ID: 12219005)
1. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.
Chang GJ; Liu T; Feng S; Bedolli M; O'rourke RW; Schmidt G; Roberts JP; Stock PG
Surgery; 2002 Aug; 132(2):149-56. PubMed ID: 12219005
[TBL] [Abstract][Full Text] [Related]
2. Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation.
Nomura M; Yamashita K; Murakami M; Takehara M; Echizenya H; Sunahara M; Kitagawa N; Fujita M; Furukawa H; Uede T; Todo S
Transplantation; 2002 May; 73(9):1403-10. PubMed ID: 12023617
[TBL] [Abstract][Full Text] [Related]
3. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
[TBL] [Abstract][Full Text] [Related]
4. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model.
Kanaya K; Tsuchida Y; Inobe M; Murakami M; Hirose T; Kon S; Kawaguchi S; Wada T; Yamashita T; Ishii S; Uede T
Transplantation; 2003 Feb; 75(3):275-81. PubMed ID: 12589145
[TBL] [Abstract][Full Text] [Related]
5. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
[TBL] [Abstract][Full Text] [Related]
6. Dimeric but not monomeric soluble CD40 prolongs allograft survival and generates regulatory T cells that inhibit CTL function.
Masunaga T; Yamashita K; Sakihama H; Hashimoto T; Hua N; Imai A; Inobe M; Miyazaki T; Todo S; Uede T
Transplantation; 2005 Dec; 80(11):1614-22. PubMed ID: 16371933
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury.
Ke B; Shen XD; Gao F; Busuttil RW; Löwenstein PR; Castro MG; Kupiec-Weglinski JW
Mol Ther; 2004 Jan; 9(1):38-45. PubMed ID: 14741776
[TBL] [Abstract][Full Text] [Related]
8. Bicistronic adenovirus-mediated gene transfer of CTLA4Ig gene and CD40Ig gene result in indefinite survival of islet xenograft.
Jin YZ; Xie SS
Transplant Proc; 2003 Dec; 35(8):3165-6. PubMed ID: 14698004
[TBL] [Abstract][Full Text] [Related]
9. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation.
Tu Y; Arima T; Flye MW
Transplantation; 1997 Jan; 63(2):177-81. PubMed ID: 9020314
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
11. Novel CD40-IgG adenovirus-mediated gene therapy as a potent immunosuppressive treatment for liver transplantation in rats.
Nomura M; Yamashita K; Murakami M; Takehara M; Konishi M; Echizenya H; Yanagida N; Sunahara M; Kitagawa N; Furukawa H; Uede T; Todo S
Transplant Proc; 2001; 33(1-2):189. PubMed ID: 11266774
[No Abstract] [Full Text] [Related]
12. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.
Bartlett AS; McCall JL; Ameratunga R; Howden B; Ramadas R; Yeong ML; Benjamin CD; Hess D; Munn SR
J Surg Res; 2003 Nov; 115(1):1-8. PubMed ID: 14572766
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
14. Transfection of CD40Ig into liver prevents acute rejection in rat liver transplantation.
Zhu JY; Liu YN; Wang D; Li T; Leng XS
Transplant Proc; 2005 Dec; 37(10):4571-4. PubMed ID: 16387173
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
[TBL] [Abstract][Full Text] [Related]
17. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
Yamaguchi Y; Mori K; Bollinger RR
J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of rapamycin therapy prolongs free flap allograft survival.
Xiao B; Xia W; Zhao K; Yang Y; Fu S; Li Y; Liu B; Guo S
Plast Reconstr Surg; 2011 May; 127(5):1820-1829. PubMed ID: 21532411
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft antibody suppression induces long-term acceptance of cardiac xenografts.
Hua N; Yamashita K; Hashimoto T; Masunaga T; Fujita M; Furukawa H; Uede T; Todo S
Transplantation; 2004 Nov; 78(10):1463-70. PubMed ID: 15599310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
